Internal Medicine, Cardiovascular Disease · Portland, OR
NPI
1154693182
Since 2012
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-7400
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
705 services
Medicare patients, 2024
366
Average age 73
Drug cost, 2024
$19.6M
2,681 prescriptions
Company payments, 2025
$103K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad M Masri was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 160 times for 138 patients. In total Ahmad M Masri billed 705 services in 33 codes, and Medicare paid $38K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 160 | 138 | $13.31 | $2,129 |
| 93306 Echocardiography (TTE/TEE) | Facility | 113 | 112 | $54.91 | $6,205 |
| 99214 Office E&M - Established | Office | 84 | 79 | $75.59 | $6,349 |
| 99205 Office E&M - New | Office | 55 | 55 | $152.21 | $8,372 |
| 99215 Office E&M - Established | Office | 38 | 32 | $112.48 | $4,274 |
| 75561 MRI/MRA - Other | Facility | 24 | 24 | $101.51 | $2,436 |
| 99233 Hospital E&M - Subsequent | Facility | 23 | 13 | $97.84 | $2,250 |
| 75565 MRI/MRA - Other | Facility | 22 | 22 | $9.85 | $217 |
| 93325 Echocardiography (TTE/TEE) | Facility | 21 | 21 | $2.54 | $53.39 |
| 93308 Echocardiography (TTE/TEE) | Facility | 19 | 19 | $20.53 | $390 |
| 93321 Echocardiography (TTE/TEE) | Facility | 17 | 17 | $5.86 | $99.69 |
| 93016 Electrocardiogram | Facility | 17 | 17 | $16.07 | $273 |
| 99213 Office E&M - Established | Office | 13 | 13 | $48.24 | $627 |
| 93018 Electrocardiogram | Facility | 11 | 11 | $10.51 | $116 |
By year: 2022 $39K for 679 services; 2023 $39K for 657 services; 2024 $38K for 705 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad M Masri prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 548 prescriptions and refills. In total Ahmad M Masri wrote 2,681 Medicare prescriptions that cost $19.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 548 | 672 | 70 | $14.2M |
| Camzyos Mavacamten | 420 | 422 | 48 | $3.3M |
| Torsemide Generic | 221 | 568 | 84 | $6,857 |
| Spironolactone Generic | 210 | 558 | 66 | $2,225 |
| Eliquis Apixaban | 159 | 388 | 50 | $221K |
| Metoprolol Succinate Generic | 156 | 423 | 54 | $2,968 |
| Potassium Chloride Generic | 106 | 281 | 38 | $3,590 |
| Losartan Potassium Generic | 70 | 207 | 23 | $1,024 |
| Atorvastatin Calcium Generic | 63 | 190 | 23 | $750 |
| Amlodipine Besylate Generic | 52 | 151 | 17 | $606 |
| Vyndaqel Tafamidis Meglumine | 39 | 55 | Under 11 | $1.1M |
| Ranolazine Er Ranolazine | 36 | 98 | 14 | $4,056 |
| Verapamil Er Verapamil Hcl | 36 | 106 | 14 | $2,445 |
| Furosemide Generic | 35 | 77 | Under 11 | $239 |
| Rosuvastatin Calcium Generic | 32 | 94 | Under 11 | $360 |
Brand drugs: 1,295 claims; generic drugs: 1,386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad M Masri $103K ($103K in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca UK Limited with $36K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca UK Limited AZN | 22 | $36K |
| Pfizer Inc. PFE | 9 | $23K |
| BridgeBio Pharma, Inc. BBIO | 4 | $11K |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $9,543 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $8,644 |
| Alexion Pharmaceuticals, Inc. AZN | 10 | $8,264 |
| Ionis Pharmaceuticals, Inc. IONS | 1 | $3,140 |
| Lexicon Pharmaceuticals, Inc. LXRX | 3 | $2,344 |
| Ge Healthcare GEHC | 1 | $150 |
| Abbott Laboratories ABT | 1 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.